# Rituximab for Pulmonary Sarcoidosis

> **NCT00855205** · PHASE2 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 10 (actual)

## Conditions studied

- Sarcoidosis

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00855205
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855205, "Rituximab for Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00855205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*